SFA002

SFA002

New oral drugs to treat autoimmune diseases and cancer

0 followers

A radically new approach to treat autoimmune diseases (psoriasis, RA, psoriatic arthritis, IBS, Crohn's, MS and Lupus) and cancers that evolve from chronic inflammation (liver cancer, pancreatic cancer), with an oral drug.

SFA002 launches

Launch date
SFA002
SFA002 New oral drugs to treat autoimmune diseases and cancer

Launched on July 7th, 2021